TCIM
TXMD icon

TIAA CREF Investment Management’s TherapeuticsMD TXMD Stock Holding History

TIAA CREF Investment Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.65M Sell
6,795
-201
-3% -$53.2K ﹤0.01% 2093
2018
Q4 		$1.33M Sell
6,996
-184
-3% -$44.9K ﹤0.01% 2169
2018
Q3 		$2.35M Sell
7,180
-217
-3% -$66.5K ﹤0.01% 2042
2018
Q2 		$2.31M Sell
7,397
-522
-7% -$159K ﹤0.01% 2096
2018
Q1 		$1.93M Buy
7,919
+42
+0.5% +$11.8K ﹤0.01% 2127
2017
Q4 		$2.38M Sell
7,877
-321
-4% -$89.4K ﹤0.01% 2035
2017
Q3 		$2.17M Sell
8,198
-226
-3% -$65.3K ﹤0.01% 2122
2017
Q2 		$2.22M Buy
8,424
+604
+8% +$151K ﹤0.01% 2116
2017
Q1 		$2.81M Sell
7,820
-659
-8% -$204K ﹤0.01% 1932
2016
Q4 		$2.45M Sell
8,479
-452
-5% -$140K ﹤0.01% 2068
2016
Q3 		$3.04K Sell
8,931
-27
-0.3% -$9.86K ﹤0.01% 1921
2016
Q2 		$3.81M Buy
8,958
+220
+3% +$90.7K ﹤0.01% 1736
2016
Q1 		$2.8M Buy
8,738
+512
+6% +$175K ﹤0.01% 1898
2015
Q4 		$4.26M Sell
8,226
-146
-2% -$53.9K ﹤0.01% 1666
2015
Q3 		$2.45M Sell
8,372
-333
-4% -$118K ﹤0.01% 2022
2015
Q2 		$3.42M Buy
8,705
+759
+10% +$268K ﹤0.01% 1950
2015
Q1 		$2.4M Buy
7,946
+467
+6% +$114K ﹤0.01% 2122
2014
Q4 		$1.66M Sell
7,479
-46
-0.6% -$9.49K ﹤0.01% 2360
2014
Q3 		$1.75M Sell
7,525
-199
-3% -$50.1K ﹤0.01% 2312
2014
Q2 		$1.71M Buy
7,724
+792
+11% +$176K ﹤0.01% 2400
2014
Q1 		$2.19M Sell
6,932
-127
-2% -$40.4K ﹤0.01% 2192
2013
Q4 		$1.84M Buy
7,059
+674
+11% +$148K ﹤0.01% 2305
2013
Q3 		$935K Buy
6,385
+47
+0.7% +$5.68K ﹤0.01% 2645
2013
Q2 		$960K Buy
+6,338
New +$868K ﹤0.01% 2608

Other funds holding TXMD

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

TIAA CREF Investment Management's TXMD Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its TherapeuticsMD (TXMD) stake by 2.9% in Q1 2019, selling an estimated $53.2K and leaving 6,795 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2093.

TIAA CREF Investment Management first reported a position in TXMD in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.26M in Q4 2015. 146 funds tracked by Wall St. Rank hold TXMD as of Q1 2019.

  • TIAA CREF Investment Management held 6,795 shares of TherapeuticsMD worth $1.65M as of Q1 2019.
  • TIAA CREF Investment Management sold 201 TherapeuticsMD shares in Q1 2019, an estimated $53.2K.
  • TherapeuticsMD made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2093 holding.
  • TIAA CREF Investment Management first reported a position in TherapeuticsMD in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's TherapeuticsMD position peaked at $4.26M in Q4 2015.
  • 146 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.